Lexicon Pharmaceuticals (LXRX) Interest Expenses (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Interest Expenses of $4.3 million for Q1 2026, up 44.88% year-over-year from $3.0 million in Q1 2025, and up 111.72% quarter-over-quarter from $2.0 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Interest Expenses (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Interest Expenses for 17 consecutive years, with $4.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 44.88% year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (down 68.38% YoY), while the FY2025 annual figure was $11.6 million, down 97.23% from the prior year.
- Interest Expenses grew to $4.3 million in Q1 2026 per LXRX's latest filing, from $2.0 million in the prior quarter.
- Across five years, Interest Expenses topped out at $10.3 million in Q3 2023 and bottomed at -$4.5 million in Q4 2022.
- Historically, Interest Expenses has averaged $3.6 million across 5 years, with a median of $3.9 million in 2024.
- Annual changes were most pronounced in 2022 — Interest Expenses plunged 4913.98% — and 2023, when it jumped 1555.45%.
- Lexicon Pharmaceuticals' Interest Expenses stood at -$4.5 million in 2022, then surged by 241.48% to $6.3 million in 2023, then plunged by 39.09% to $3.9 million in 2024, then plunged by 47.36% to $2.0 million in 2025, then jumped by 111.72% to $4.3 million in 2026.
- Business Quant data shows LXRX's Interest Expenses at $4.3 million in Q1 2026, $2.0 million in Q4 2025, and $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | 10.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.79 Mn |
| Jun 30, 2026 | 10.79 Mn |
| Mar 31, 2026 | 4.30 Mn |
| Mar 31, 2026 | 4.30 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 4.50 Mn |
| Sep 30, 2025 | 4.50 Mn |
| Jun 30, 2025 | 7.91 Mn |
| Jun 30, 2025 | 7.91 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 3.86 Mn |
| Dec 31, 2024 | 3.86 Mn |
| Sep 30, 2024 | 4.56 Mn |
| Sep 30, 2024 | 4.56 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 4.95 Mn |
| Mar 31, 2024 | 4.95 Mn |